0001104659-23-062373.txt : 20230518 0001104659-23-062373.hdr.sgml : 20230518 20230518203148 ACCESSION NUMBER: 0001104659-23-062373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230516 FILED AS OF DATE: 20230518 DATE AS OF CHANGE: 20230518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xynos Konstantinos CENTRAL INDEX KEY: 0001956241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 23937736 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 500 UNICORN PARK DRIVE CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2316199-4_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-05-16 0 0001737953 Replimune Group, Inc. REPL 0001956241 Xynos Konstantinos C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK DRIVE WOBURN MA 01801 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-05-16 4 S 0 771 18.05 D 120027 D Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.21. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ Shawn Glidden, attorney-in-fact 2023-05-18